Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04427527 · ClinicalTrials.gov registry record · NA
Accelerating Colorectal Cancer Screening Through Implementation Science in Appalachia
A NA study, sponsored by University of Kentucky.
- Completed
- Registry status
- NA
- Development phase
- 5,413
- Enrollment target
NCT04427527: Completed NA study, sponsored by University of Kentucky.
NCT04427527 is a NA study that has completed, run by University of Kentucky. The registered enrollment target is 5,413 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (286% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04427527, a NA study, has completed, sponsored by University of Kentucky.
- COMPLETED
- Registry status
- NA
- Development phase
- 5,413 participants
- Enrollment target
Study Summary
This project aims to implement a multi-level group randomized trial, delayed intervention that includes components targeting clinics, providers, patients, and the community to increase colorectal cancer (CRC) screening, follow-up, and referral-to-care among patients age 50-74 in 12 counties in Appalachian Kentucky and Ohio. The 12 counties will be assigned to one of two study groups (early vs. delayed) and outcome measures (rate of CRC screening) will be obtained from clinic-level electronic health record data and a county-level behavioral assessment telephone survey. The hypothesis for the project is that the multi-level intervention will increase the clinic and county level CRC screening rates.
Primary Outcome
This is the Y1 follow-up clinic-reported aggregated CRC screening rate for eligible patients age 50-74 at the clinic-level for Pair 2 and Pair 3 early and delayed clinics (n=8). Pair 1 clinics (n=4) were excluded. Percentages reported are based on aggregated numerator (total # of patients age 50-74 screened for CRC at Pair 2 and 3 early/delayed clinics)/aggregated denominator (total # of patients age 50-74 eligible for CRC screening at Pair 2 and 3 early/delayed clinics).
Interventions
- BEHAVIORAL Multi-level intervention to increase CRC screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,413 participants |
| Start Date | 2020-08-19 |
| Est. Completion | 2025-03-31 |
| Phase | NA |
What the finished NCT04427527 record still lists
NCT04427527 is an interventional study that assigns participants to a tested intervention. Its 5,413 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (286% higher).
The record links to 0 conditions, and to 1 intervention - of which Multi-level intervention to increase CRC screening is the first listed.
NCT04427527 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04427527 about?
NCT04427527 is a clinical study titled "Accelerating Colorectal Cancer Screening Through Implementation Science in Appalachia". This project aims to implement a multi-level group randomized trial, delayed intervention that includes components targeting clinics, providers, patients, and the community to increase colorectal cancer (CRC) screening, follow-up, and referral-to-care among patients age 50-74 in 12 counties in Appal...
What is the current status of trial NCT04427527?
This trial is currently completed. It is a NA study. The enrollment target is 5,413 participants. The study started on 2020-08-19. Estimated completion is 2025-03-31.
What interventions are being tested in trial NCT04427527?
The interventions under investigation include: Multi-level intervention to increase CRC screening (BEHAVIORAL).
Who is sponsoring clinical trial NCT04427527?
This trial is sponsored by University of Kentucky, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04427527's enrollment target sits among peer trials
5,413 24th of 2000 higher than 1,977 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05722769 · 5,408 participants · NA
CSTOP Now! Child Sex Trafficking Stops With You
- NCT05836987 · 5,350 participants · Phase 3
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
- NCT04295486 · 5,478 participants · Phase 2
Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty
- NCT05373771 · 5,328 participants · NA
Sickle Cell Improvement: Enhancing Care in the Emergency Department
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI